Management of Neurorehabilitation During the COVID-19 Pandemic

Year 2020, , 10 - 13, 30.11.2020

Şevki Sahin

https://doi.org/10.18678/dtfd.775214

Cited By: 3

Abstract

Neurorehabilitation originates from the concept of neuroplasticity and it has an important role -both physical and cognitive- in the restoration of a damaged nervous system. Interruption in neurorehabilitation negatively affects a patient’s prognosis. Unfortunately, after the World Health Organization declared coronavirus disease 2019 (COVID-19) a pandemic, there were some disruptions in neurorehabilitation practices. Therefore, according to the principles of infection prevention and protection, the issue of developing new neurorehabilitation management strategies was raised. Providing appropriate physical distancing in shared rehabilitation areas and strict training of the rehabilitation team with regard to hygiene rules are important issues in terms of preventing contamination. In new treatment schemes, options such as discharging patients from hospital at the earliest possible time, home-based treatments and telerehabilitation have become standard. Online patient-physician consultation can provide the continuity of neurorehabilitation and reduce anxiety and the feeling of social isolation felt by many patients and their families. In addition, the pandemic period can be turned into an opportunity for caregivers to learn physical and cognitive exercises and apply them to their patients. The current article focuses on the new neurorehabilitation approaches in the neurological diseases sample which includes stroke, multiple sclerosis, dementia, Parkinson’s disease and neuromuscular diseases within the context of the COVID-19 pandemic.

Keywords

COVID-19, neurorehabilitation, home-based treatment, telerehabilitation

COVID-19 Pandemisi Sürecinde Nörorehabilitasyonun Yönetimi

Abstract

Nörorehabilitasyon nöroplastisite kavramından köken alır ve hasarlanmış sinir sisteminin restorasyonunda hem fiziksel hem de bilişsel açıdan önemli bir role sahiptir. Nörorehabilitasyonda kesinti yaşanması hastanın prognozunu negatif yönde etkiler. Ne yazık ki, Dünya Sağlık Örgütü’nün koronavirüs hastalığı 2019 (coronavirus disease 2019, COVID-19)’u pandemi olarak ilan etmesinden sonra, nörorehabilitasyon uygulamalarında aksamalar olmuştur. Bu nedenle, enfeksiyon önleme ve koruma kurallarına göre yeni nörorehabilitasyon stratejileri geliştirme konusu gündeme gelmiştir. Ortak rehabilitasyon alanlarında uygun fiziksel mesafenin sağlanması ve rehabilitasyon ekibinin hijyen kuralları açısından sıkı eğitimi, bulaşmayı önleme açısından önemli konulardır. Yeni tedavi şemalarında, hastaların mümkün olan en kısa zamanda hastaneden taburcu edilmesi, evde yapılan tedaviler ve telerehabilitasyon gibi seçenekler ön plana çıkmaktadır. Çevrimiçi hasta-uzman görüşmesi, nörorehabilitasyonun devamlılığını sağlayacağı gibi hasta ve yakınlarının, anksiyetesini ve sosyal izolasyon duygusunu azaltabilir. Ayrıca pandemi dönemi, bakım verenlerin, fiziksel ve bilişsel egzersizleri öğrenerek hastalarına uygulamaları açısından bir fırsata da dönüştürülebilir. Bu makalede, COVID-19 pandemisi bağlamında; inme, multipl skleroz, demans, Parkinson hastalığı ve nöromusküler hastalıkları içeren nörolojik hastalıklar örnekleminde, yeni nörorehabilitasyon yaklaşımlarına odaklanılmıştır.

Keywords

COVID-19,, nörorehabilitasyon, evde tedavi, telerehabilitasyon

References

• Kitago T, Krakauer JW. Motor learning principles for neurorehabilitation. Handb Clin Neurol. 2013;110:93-103.
• Fujiwara T, Ushiba J, Soekadar SR. Neurorehabilitation: Neural plasticity and functional recovery 2018. Neural Plast. 2019;2019:7812148.
• Dimitrijevic MR. Outline of restorative neurology: definition, clinical practice, assessment, intervention. Clin Neurol Neurosurg. 2012;114(5):428-31.
• Leocani L, Diserens K, Moccia M, Caltagirone C. Disability through COVID-19 pandemic: Neurorehabilitation cannot wait. Eur J Neurol. 2020;[Epub ahead of print]. doi: 10.1111/ene.14320.
• Chang MC, Boudier-Revéret M. Usefulness of telerehabilitation for stroke patients during the COVID-19 pandemic. Am J Phys Med Rehabil. 2020;99(7):582.
• Sylaja PN, Srivastava MVP, Shah S, Bhatia R, Khurana D, Sharma A, et al. The SARS-CoV-2/COVID-19 pandemic and challenges in stroke care in India. Ann N Y Acad Sci. 2020;[Epub ahead of print]. doi: 10.1111/nyas.14379.
• Bartolo M, Intiso D, Lentino C, Sandrini G, Paolucci S, Zampolini M, et al. Urgent measures for the containment of the coronavirus (Covid-19) epidemic in the neurorehabilitation/rehabilitation departments in the phase of maximum expansion of the epidemic. Front Neurol. 2020;11:423.
• Smith EE, Mountain A, Hill MD, Wein TH, Blacquiere D, Casaubon LK, et al. Canadian stroke best practice guidance during the COVID-19 pandemic. Can J Neurol Sci. 2020;47(4):474-8.
• Acar T, Demirel Acıman E, Afsar N, Akcalı A, Akman Demir G, Alagöz AN, et al. The COVID-19 from neurological overview. Turk J Neurol. 2020;26(2):58-108.
• Blacquiere D, Lindsay MP, Foley N, Taralson C, Alcock S, Balg C, et al. Canadian stroke best practice recommendations: telestroke best practice guidelines update 2017. Int J Stroke. 2017;12(8):886-95.
• Gelaw AY, Janakiraman B, Gebremeskel BF, Ravichandran H. Effectiveness of home-based rehabilitation in improving physical function of persons with stroke and other physical disability: A systematic review of randomized controlled trials. J Stroke Cerebrovasc Dis. 2020;29(6):104800.
• Zhao J, Rudd A, Liu R. Challenges and potential solutions of stroke care during the coronavirus disease 2019 (COVID-19) outbreak. Stroke. 2020;51(5):1356-7.
• Naser Moghadasi A, Azadvari M, Sahraian MA. Rehabilitation recommendations for multiple sclerosis patients during the COVID-19 pandemic. Arch Iran Med. 2020;23(7):509-10.
• Sastre-Garriga J, Tintoré M, Montalban X. Keeping standards of multiple sclerosis care through the COVID-19 pandemic. Mult Scler. 2020;26(10):1153-6.
• Kalb R, Brown TR, Coote S, Costello K, Dalgas U, Garmon E, et al. Exercise and lifestyle physical activity recommendations for people with multiple sclerosis throughout the disease course. Mult Scler. 2020;26(12):1459-69.
• Wang H, Li T, Barbarino P, Gauthier S, Brodaty H, Molinuevo JL, et al. Dementia care during COVID-19. Lancet. 2020;395(10231):1190-1.
• Goodman-Casanova JM, Dura-Perez E, Guzman-Parra J, Cuesta-Vargas A, Mayoral-Cleries F. Telehealth home support during COVID-19 confinement for community-dwelling older adults with mild cognitive impairment or mild dementia: Survey study. J Med Internet Res. 2020;22(5):e19434.
• Marx KA, Scott JB, Piersol CV, Gitlin LN. Tailored activities to reduce neuropsychiatric behaviors in persons with dementia: Case report. Am J Occup Ther. 2019;73(2):7302205160p1-9.
• Ali A, Brown E, Spector A, Aguirre E, Hassiotis A. Individual cognitive stimulation therapy for people with intellectual disability and dementia: protocol of a feasibility randomised controlled trial. BMJ Open. 2018;8(12):e022136.
• Coronado RA, Albers HE, Allen JL, Clarke RG, Estrada VA, Simon CB, et al. Pain-reducing effects of physical therapist-delivered interventions: A systematic review of randomized trials among older adults with dementia. J Geriatr Phys Ther. 2020;43(3):159-69.
• Trabucchi M, De Leo D. Nursing homes or besieged castles: COVID-19 in northern Italy. Lancet Psychiatry. 2020;7(5):387-8.
• Quinn L, Macpherson C, Long K, Shah H. Promoting physical activity via telehealth in people with parkinson disease: The path forward after the COVID-19 pandemic? Phys Ther. 2020;100(10):1730-6.
• Solé G, Salort-Campana E, Pereon Y, Stojkovic T, Wahbi K, Cintas P, et al. Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network. Rev Neurol (Paris). 2020;176(6):507-15.
• Di Stefano V, Battaglia G, Giustino V, Gagliardo A, D'Aleo M, Giannini O, et al. Significant reduction of physical activity in patients with neuromuscular disease during COVID-19 pandemic: the long-term consequences of quarantine. J Neurol. 2020;[Epub ahead of print]. doi: 10.1007/s00415-020-10064-6.